The effectiveness of early interventions for post-stroke spasticity: a systematic review.
Abstract
[PURPOSE] To synthesize evidence on the effect of early post-stroke spasticity interventions.
[METHODS] Systematic literature search (PubMed, Embase, and Web of Science) encompassing studies on spasticity reducing interventions within 3 months post stroke on outcome defined within the International Classification of Functioning (ICF).
[RESULTS] In total, 27 studies were identified with = 1.658 cases. Botulinum toxin (2-12 weeks; 10 studies, = 794) showed consistent and significant reduced spasticity by Modified Ashworth Scale (MAS) or electromyography (EMG). Electrical muscle stimulation (1-8 weeks; 6 studies, = 335) showed lower MAS/Composite Spasticity Scale scores in 4 studies. Transcranial stimulation (3 studies; = 131), oral spasmolytics (1 study; = 38), shockwave (1 study; = 40), orthotics (3 studies; = 197 and robot-assisted therapy (3 studies; = 123) showed inconclusive results. Effects on ICF activity domain could not be established due to limited data and large outcome measures heterogeneity. One out of two studies showed significant benefit for early compared to late BoNT intervention (< 90 vs> 90 days).
[CONCLUSION] This study provides evidence for early applied (<3 months) BoNT to effectively reduce spasticity and probable effectiveness of electrical stimulation. Establishing effects of interventions in the acute/hospitalization phase (<7 days) needs further work, specifically on the ICF activity domain. Standardization of outcome measures is required.
[METHODS] Systematic literature search (PubMed, Embase, and Web of Science) encompassing studies on spasticity reducing interventions within 3 months post stroke on outcome defined within the International Classification of Functioning (ICF).
[RESULTS] In total, 27 studies were identified with = 1.658 cases. Botulinum toxin (2-12 weeks; 10 studies, = 794) showed consistent and significant reduced spasticity by Modified Ashworth Scale (MAS) or electromyography (EMG). Electrical muscle stimulation (1-8 weeks; 6 studies, = 335) showed lower MAS/Composite Spasticity Scale scores in 4 studies. Transcranial stimulation (3 studies; = 131), oral spasmolytics (1 study; = 38), shockwave (1 study; = 40), orthotics (3 studies; = 197 and robot-assisted therapy (3 studies; = 123) showed inconclusive results. Effects on ICF activity domain could not be established due to limited data and large outcome measures heterogeneity. One out of two studies showed significant benefit for early compared to late BoNT intervention (< 90 vs> 90 days).
[CONCLUSION] This study provides evidence for early applied (<3 months) BoNT to effectively reduce spasticity and probable effectiveness of electrical stimulation. Establishing effects of interventions in the acute/hospitalization phase (<7 days) needs further work, specifically on the ICF activity domain. Standardization of outcome measures is required.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | muscle
|
scispacy | 1 | ||
| 합병증 | oral spasmolytics
|
scispacy | 1 | ||
| 약물 | [RESULTS]
|
scispacy | 1 | ||
| 기법 | robot-assisted
|
로봇수술 | dict | 1 | |
| 질환 | post-stroke spasticity
|
scispacy | 1 | ||
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | stroke
|
C0038454
Cerebrovascular accident
|
scispacy | 1 | |
| 질환 | EMG
→ electromyography
|
scispacy | 1 |
MeSH Terms
Humans; Muscle Spasticity; Stroke Rehabilitation; Stroke; Electric Stimulation Therapy; Neuromuscular Agents; Treatment Outcome; Botulinum Toxins
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.